The addition of Cytosorb in patients on VA-ECMO improves urinary output and ICU survival.

Daniel Lovrić Marijan Pašalić Stefan Križanac Karla Kovačić Boško Skorić Hrvoje Jurin Davor Miličić Vedran Premuzic

Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2023)

While a decrease in vasopressor doses was already associated with CytoSorb use, this is the first study showing an increase in urinary output and a trend towards better survival among patients on VA ECMO treated with CytoSorb.

Keyphrases

extracorporeal membrane oxygenation
newly diagnosed
acute respiratory distress syndrome
end stage renal disease
intensive care unit
prognostic factors
free survival
respiratory failure
patient reported outcomes
patient reported